{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:16:51Z","timestamp":1793812611564,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea","award":["2025S1A5B5A16005647"],"award-info":[{"award-number":["2025S1A5B5A16005647"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anxiety is a prevalent and clinically significant non-motor symptom in individuals with Parkinson\u2019s disease (PD), yet the overall efficacy of psychological interventions for anxiety in this population remains unclear. This meta-analysis aimed to evaluate the effectiveness of psychological and mind\u2013body interventions in reducing anxiety symptoms among individuals with PD and to explore potential differences according to theoretical orientation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomized controlled trials (RCTs) examining psychological or mind\u2013body interventions reporting anxiety outcomes in individuals with PD were systematically identified in four databases searched to 27 July 2026. Effect sizes were calculated as standardized mean differences using Hedges\u2019 g within a random-effects model, with between-study variance estimated by restricted maximum likelihood and inference based on the Hartung\u2013Knapp adjustment. Heterogeneity was assessed using Cochran\u2019s Q and I\u00b2 statistics, and a prediction interval was calculated. Subgroup analyses compared cognitive\u2013behavioral and interpersonal therapies with mindfulness- and mind\u2013body-based approaches, and active with inactive control conditions. Sensitivity analyses, including leave-one-out procedures and exclusion of trials at high risk of bias, were performed. Publication bias was examined using funnel plot inspection and Egger\u2019s regression test, and the certainty of evidence with GRADE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across 13 comparisons from 13 trials and 877 participants, psychological and mind\u2013body interventions were associated with a statistically significant reduction in anxiety symptoms (Hedges\u2019 g\u2009=\u2009\u2212\u20090.46, 95% CI [\u2212\u20090.67, \u2212\u20090.25]). Heterogeneity was moderate (I\u00b2 = 40.7%, 95% CI 0% to 79%), and the 95% prediction interval, \u2212\u20091.00 to +\u20090.08, included the null. Cognitive\u2013behavioral and interpersonal therapies showed a significant effect (g\u2009=\u2009\u2212\u20090.57), whereas the estimate for mindfulness- and mind\u2013body-based approaches was smaller and its interval included the null (g\u2009=\u2009\u2212\u20090.25); there was no statistical evidence of subgroup differences. Subgroup findings should be interpreted cautiously because of the small number of comparisons within each category. Eleven of the thirteen comparisons used an inactive control condition (g\u2009=\u2009\u2212\u20090.53), and the estimate against active comparators was imprecise (g\u2009=\u2009\u2212\u20090.22). A similar reduction was observed at follow-up in nine trials (g\u2009=\u2009\u2212\u20090.39). Sensitivity analyses confirmed the stability of the pooled effect, and no clear evidence of publication bias was detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Psychological and mind\u2013body interventions may reduce anxiety symptoms in individuals with PD, and a similar reduction was observed at follow-up. However, the clinical interpretation of this effect requires caution because different anxiety scales were used across trials, the number of included studies was limited, several studies were rated as having a high risk of bias, the prediction interval included the null, and the effect derives principally from comparisons with inactive control conditions. The overall certainty of the evidence was very low. Although no statistically significant differences between theoretical approaches were observed, this subgroup finding should be interpreted as exploratory, and larger trials recruiting participants with clinically significant anxiety, using active comparators and standardized follow-up, are needed before firm clinical recommendations can be made.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40359-026-05436-y","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:54:41Z","timestamp":1787723681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of psychological interventions for anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis including mindfulness and mind\u2013body approaches"],"prefix":"10.1186","volume":"14","author":[{"given":"Jiyoung","family":"Gwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinse","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"5436_CR1","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.26643","volume":"31 8","author":"MP Broen","year":"2016","unstructured":"Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson\u2019s disease: A systematic review and meta-analysis. Mov Disord. 2016;31 8:1125\u201333. https:\/\/doi.org\/10.1002\/mds.26643.","journal-title":"Mov Disord"},{"key":"5436_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/ene.13242","volume":"24 4","author":"GM Pontone","year":"2017","unstructured":"Pontone GM. Anxiety in Parkinson\u2019s: a complex syndrome of non-dopaminergic and dopaminergic etiology. Eur J Neurol. 2017;24 4:541\u20132. https:\/\/doi.org\/10.1111\/ene.13242.","journal-title":"Eur J Neurol"},{"key":"5436_CR3","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1111\/ene.15890","volume":"30 9","author":"H Wang","year":"2023","unstructured":"Wang H, Zhao Y, Schrag A. Development of anxiety in early Parkinson\u2019s disease: A clinical and biomarker study. Eur J Neurol. 2023;30 9:2661\u20138. https:\/\/doi.org\/10.1111\/ene.15890.","journal-title":"Eur J Neurol"},{"key":"5436_CR4","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.prdoa.2021.100089","volume":"4","author":"MR Landers","year":"2021","unstructured":"Landers MR, Jacobson KM, Matsunami NE, McCarl HE, Regis MT, Longhurst JK. A vicious cycle of fear of falling avoidance behavior in Parkinson\u2019s disease: A path analysis. Clin Park Relat Disord. 2021;4:100089. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100089.","journal-title":"Clin Park Relat Disord"},{"key":"5436_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/mdc3.70056","volume":"12 7","author":"A Cronin-Golomb","year":"2025","unstructured":"Cronin-Golomb A, McDaniels B, Mathur S, Pontone GM, Reynolds GO, Subramanian I. Using Principles of Cognitive Behavioral Therapy to Treat Anxiety in Parkinson\u2019s Disease. Mov Disord Clin Pract. 2025;12 7:895\u2013903. https:\/\/doi.org\/10.1002\/mdc3.70056.","journal-title":"Mov Disord Clin Pract"},{"key":"5436_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/bcp.70553","author":"N Nieminen","year":"2026","unstructured":"Nieminen N, Tolppanen AM, Kaasinen V, Koponen M, Hartikainen S. Psychotropic medication use among community dwellers with and without Parkinson\u2019s disease - A nationwide cohort study. Br J Clin Pharmacol. 2026. https:\/\/doi.org\/10.1002\/bcp.70553.","journal-title":"Br J Clin Pharmacol"},{"key":"5436_CR7","doi-asserted-by":"publisher","unstructured":"Wu X, Shi M, Lian Y, Zhang H. Cognitive behavioral therapy approaches to the improvement of mental health in Parkinson\u2019s disease patients: a systematic review and meta-analysis. BMC Neurol. 2024;24(1:352). https:\/\/doi.org\/10.1186\/s12883-024-03859-x.","DOI":"10.1186\/s12883-024-03859-x"},{"key":"5436_CR8","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/mds.28533","volume":"36 11","author":"AJH Moonen","year":"2021","unstructured":"Moonen AJH, Mulders AEP, Defebvre L, Duits A, Flinois B, K\u00f6hler S, et al. Cognitive Behavioral Therapy for Anxiety in Parkinson\u2019s Disease: A Randomized Controlled Trial. Mov Disord. 2021;36 11:2539\u201348. https:\/\/doi.org\/10.1002\/mds.28533.","journal-title":"Mov Disord"},{"key":"5436_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/mds.28345","volume":"36 1","author":"A van der Heide","year":"2021","unstructured":"van der Heide A, Meinders MJ, Speckens AEM, Peerbolte TF, Bloem BR, Helmich RC. Stress and Mindfulness in Parkinson\u2019s Disease: Clinical Effects and Potential Underlying Mechanisms. Mov Disord. 2021;36 1:64\u201370. https:\/\/doi.org\/10.1002\/mds.28345.","journal-title":"Mov Disord"},{"key":"5436_CR10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/978-1-4419-1005-9_215","volume-title":"Encyclopedia of Behavioral Medicine","author":"S Folkman","year":"2013","unstructured":"Folkman S, Stress. Appraisal and Coping. In: Gellman MD, Turner JR, editors. Encyclopedia of Behavioral Medicine. New York, NY: Springer New York; 2013. pp. 1913\u20135."},{"key":"5436_CR11","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1007\/s10072-024-07659-6","volume":"45 11","author":"AZ Alnajjar","year":"2024","unstructured":"Alnajjar AZ, Abouelmagd ME, Krayim A, AbdelMeseh M, Bushara N, Nabil Y. Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson\u2019s disease patients: an updated systematic review and meta-analysis. Neurol Sci. 2024;45 11:5277\u201390. https:\/\/doi.org\/10.1007\/s10072-024-07659-6.","journal-title":"Neurol Sci"},{"key":"5436_CR12","doi-asserted-by":"publisher","first-page":"e79510","DOI":"10.1371\/journal.pone.0079510","volume":"8 11","author":"L Troeung","year":"2013","unstructured":"Troeung L, Egan SJ, Gasson N. A meta-analysis of randomized placebo-controlled treatment trials for depression and anxiety in Parkinson\u2019s disease. PLoS ONE. 2013;8 11:e79510. https:\/\/doi.org\/10.1371\/journal.pone.0079510.","journal-title":"PLoS ONE"},{"key":"5436_CR13","doi-asserted-by":"publisher","unstructured":"Yu X, Wu Q, Liu Y, Han P, Chen X, Guo Q. Cognitive behavioral therapy for anxiety and depression symptoms in people of Parkinson\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci. 2025;17\u20132025. https:\/\/doi.org\/10.3389\/fnagi.2025.1440850.","DOI":"10.3389\/fnagi.2025.1440850"},{"key":"5436_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/0145445510393730","volume":"35 2","author":"LA Brown","year":"2011","unstructured":"Brown LA, Gaudiano BA, Miller IW. Investigating the similarities and differences between practitioners of second- and third-wave cognitive-behavioral therapies. Behav Modif. 2011;35 2:187\u2013200. https:\/\/doi.org\/10.1177\/0145445510393730.","journal-title":"Behav Modif"},{"key":"5436_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"5436_CR16","doi-asserted-by":"publisher","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1:135). https:\/\/doi.org\/10.1186\/1471-2288-14-135.","DOI":"10.1186\/1471-2288-14-135"},{"key":"5436_CR17","doi-asserted-by":"publisher","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Multiple comparisons within a study. In: Introduction to meta-analysis. Chichester: John Wiley & Sons; 2009. p. 239\u201342. https:\/\/doi.org\/10.1002\/9780470743386.ch25.","DOI":"10.1002\/9780470743386.ch25"},{"key":"5436_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomized trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"5436_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4\u201313. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.05.006.","journal-title":"J Clin Epidemiol"},{"key":"5436_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2307\/1164588","volume":"6 2","author":"LV Hedges","year":"1981","unstructured":"Hedges LV. Distribution Theory for Glass\u2019s Estimator of Effect Size and Related Estimators. J Educational Stat. 1981;6 2:107\u201328. https:\/\/doi.org\/10.2307\/1164588.","journal-title":"J Educational Stat"},{"key":"5436_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.09.002","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015. https:\/\/doi.org\/10.1016\/j.cct.2015.09.002. 45 Pt A:139\u2009\u2013\u200945.","journal-title":"Contemp Clin Trials"},{"key":"5436_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"T Huedo-Medina","year":"2006","unstructured":"Huedo-Medina T, Sanchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing Heterogeneity in Meta-Analysis: Q Statistic or I Index? Psychol Methods. 2006;11:193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193.","journal-title":"Psychol Methods"},{"key":"5436_CR23","doi-asserted-by":"crossref","unstructured":"Page MJ, Higgins JPT, Sterne JAC. Assessing risk of bias due to missing results in a synthesis. In: Cochrane Handbook for Systematic Reviews of Interventions. 2019. pp. 349\u2009\u2013\u200974.","DOI":"10.1002\/9781119536604.ch13"},{"key":"5436_CR24","doi-asserted-by":"crossref","unstructured":"Boutron I, Page MJ, Higgins JPT, Altman DG, Lundh A, Hr\u00f3bjartsson A et al. Considering bias and conflicts of interest among the included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. 2019. pp. 177\u2013204.","DOI":"10.1002\/9781119536604.ch7"},{"key":"5436_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315 7109","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315 7109:629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"1","key":"5436_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0891988720988901","volume":"35","author":"A Bogosian","year":"2022","unstructured":"Bogosian A, Hurt CS, Hindle JV, McCracken LM, Vasconcelos ESDA, Axell S, et al. Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson\u2019s. J Geriatr Psychiatry Neurol. 2022;35(1):155\u201367. https:\/\/doi.org\/10.1177\/0891988720988901.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"5436_CR27","doi-asserted-by":"publisher","first-page":"763350","DOI":"10.3389\/fpsyg.2021.763350","volume":"12","author":"TM Buchwitz","year":"2021","unstructured":"Buchwitz TM, Maier F, Greuel A, Thieken F, Steidel K, Jakobs V, et al. Pilot Study of Mindfulness Training on the Self-Awareness of Motor Symptoms in Parkinson\u2019s Disease - A Randomized Controlled Trial. Front Psychol. 2021;12:763350. https:\/\/doi.org\/10.3389\/fpsyg.2021.763350.","journal-title":"Front Psychol"},{"key":"5436_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/appi.ajp.2011.10111669","volume":"168 10","author":"RD Dobkin","year":"2011","unstructured":"Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, et al. Cognitive-behavioral therapy for depression in Parkinson\u2019s disease: a randomized, controlled trial. Am J Psychiatry. 2011;168 10:1066\u201374. https:\/\/doi.org\/10.1176\/appi.ajp.2011.10111669.","journal-title":"Am J Psychiatry"},{"key":"5436_CR29","doi-asserted-by":"publisher","first-page":"e1764","DOI":"10.1212\/WNL.0000000000009292","volume":"94 16","author":"RD Dobkin","year":"2020","unstructured":"Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial. Neurology. 2020;94 16:e1764\u201373. https:\/\/doi.org\/10.1212\/WNL.0000000000009292.","journal-title":"Neurology"},{"key":"5436_CR30","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/mds.28548","volume":"36 11","author":"RD Dobkin","year":"2021","unstructured":"Dobkin RD, Mann SL, Weintraub D, Rodriguez KM, Miller RB, St Hill L, et al. Innovating Parkinson\u2019s Care: A Randomized Controlled Trial of Telemedicine Depression Treatment. Mov Disord. 2021;36 11:2549\u201358. https:\/\/doi.org\/10.1002\/mds.28548.","journal-title":"Mov Disord"},{"key":"5436_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/mds.30061","volume":"40 8","author":"D Koszycki","year":"2025","unstructured":"Koszycki D, Taljaard M, Bradwejn J, Lee C, Tasca GA, Grimes DA. Interpersonal Psychotherapy for the Treatment of Depression in Parkinson\u2019s Disease: Results of a Randomized Controlled Trial. Mov Disord. 2025;40 8:1539\u201350. https:\/\/doi.org\/10.1002\/mds.30061.","journal-title":"Mov Disord"},{"issue":"2","key":"5436_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JPD-191894","volume":"10","author":"M Kraepelien","year":"2020","unstructured":"Kraepelien M, Schibbye R, Mansson K, Sundstrom C, Riggare S, Andersson G, et al. Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson\u2019s Disease: A Randomized Controlled Trial. J Parkinsons Dis. 2020;10(2):653\u201364. https:\/\/doi.org\/10.3233\/JPD-191894.","journal-title":"J Parkinsons Dis"},{"key":"5436_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/jamaneurol.2019.0534","volume":"76 7","author":"JYY Kwok","year":"2019","unstructured":"Kwok JYY, Kwan JCY, Auyeung M, Mok VCT, Lau CKY, Choi KC, et al. Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2019;76 7:755\u201363. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0534.","journal-title":"JAMA Neurol"},{"issue":"2","key":"5436_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000543457","volume":"94","author":"JYY Kwok","year":"2025","unstructured":"Kwok JYY, Chan LML, Lai CA, Ho PWL, Choi ZY, Auyeung M, et al. Effects of Meditation and Yoga on Anxiety, Depression and Chronic Inflammation in Patients with Parkinson\u2019s Disease: A Randomized Clinical Trial. Psychother Psychosom. 2025;94(2):101\u201318. https:\/\/doi.org\/10.1159\/000543457.","journal-title":"Psychother Psychosom"},{"key":"5436_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","volume":"80 9","author":"D Okai","year":"2013","unstructured":"Okai D, Askey-Jones S, Samuel M, O\u2019Sullivan SS, Chaudhuri KR, Martin A, et al. Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology. 2013;80 9:792\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3182840678.","journal-title":"Neurology"},{"key":"5436_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-244X-14-19","volume":"14","author":"L Troeung","year":"2014","unstructured":"Troeung L, Egan SJ, Gasson N. A waitlist-controlled trial of group cognitive behavioral therapy for depression and anxiety in Parkinson\u2019s disease. BMC Psychiatry. 2014;14:19. https:\/\/doi.org\/10.1186\/1471-244X-14-19.","journal-title":"BMC Psychiatry"},{"key":"5436_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/07317115.2019.1580811","volume":"42 4","author":"VM Wuthrich","year":"2019","unstructured":"Wuthrich VM, Rapee RM. Telephone-Delivered Cognitive Behavioral Therapy for Treating Symptoms of Anxiety and Depression in Parkinson\u2019s Disease: A Pilot Trial. Clin Gerontol. 2019;42 4:444\u201353. https:\/\/doi.org\/10.1080\/07317115.2019.1580811.","journal-title":"Clin Gerontol"},{"key":"5436_CR38","first-page":"73","volume":"8 2","author":"J Kabat-Zinn","year":"2003","unstructured":"Kabat-Zinn J. Mindfulness-based stress reduction (MBSR). Constructivism Hum Sci. 2003;8 2:73\u2013107.","journal-title":"Constructivism Hum Sci"}],"container-title":["BMC Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-026-05436-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-026-05436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40359-026-05436-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:31:06Z","timestamp":1792495866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40359-026-05436-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5436"],"URL":"https:\/\/doi.org\/10.1186\/s40359-026-05436-y","relation":{},"ISSN":["2050-7283"],"issn-type":[{"value":"2050-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of previously published studies and did not involve the collection of new data from human participants or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1512"}}